These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25169794)

  • 1. Molecular characterization of immortalized normal and dysplastic oral cell lines.
    Dickman CT; Towle R; Saini R; Garnis C
    J Oral Pathol Med; 2015 May; 44(5):329-36. PubMed ID: 25169794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibroblast gene expression profile reflects the stage of tumour progression in oral squamous cell carcinoma.
    Lim KP; Cirillo N; Hassona Y; Wei W; Thurlow JK; Cheong SC; Pitiyage G; Parkinson EK; Prime SS
    J Pathol; 2011 Mar; 223(4):459-69. PubMed ID: 21294120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
    Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
    J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations in oral squamous cell carcinoma progression detected by combining array-based comparative genomic hybridization and multiplex ligation-dependent probe amplification.
    Cha JD; Kim HJ; Cha IH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 May; 111(5):594-607. PubMed ID: 21334929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic copy number alterations detected by ultra-deep targeted sequencing predict prognosis in oral cavity squamous cell carcinoma.
    Peng CH; Liao CT; Ng KP; Tai AS; Peng SC; Yeh JP; Chen SJ; Tsao KC; Yen TC; Hsieh WP
    Oncotarget; 2015 Aug; 6(23):19891-906. PubMed ID: 26087196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated Analysis and MicroRNA Expression Profiling Identified Seven miRNAs Associated With Progression of Oral Squamous Cell Carcinoma.
    Yan ZY; Luo ZQ; Zhang LJ; Li J; Liu JQ
    J Cell Physiol; 2017 Aug; 232(8):2178-2185. PubMed ID: 27935034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer.
    Kozaki K; Imoto I; Mogi S; Omura K; Inazawa J
    Cancer Res; 2008 Apr; 68(7):2094-105. PubMed ID: 18381414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically-defined novel oral squamous cell carcinoma cell lines for the development of molecular therapies.
    Fadlullah MZ; Chiang IK; Dionne KR; Yee PS; Gan CP; Sam KK; Tiong KH; Ng AK; Martin D; Lim KP; Kallarakkal TG; Mustafa WM; Lau SH; Abraham MT; Zain RB; Rahman ZA; Molinolo A; Patel V; Gutkind JS; Tan AC; Cheong SC
    Oncotarget; 2016 May; 7(19):27802-18. PubMed ID: 27050151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrative analysis of the microRNA-mRNA response to radiochemotherapy in primary head and neck squamous cell carcinoma cells.
    Summerer I; Hess J; Pitea A; Unger K; Hieber L; Selmansberger M; Lauber K; Zitzelsberger H
    BMC Genomics; 2015 Sep; 16(1):654. PubMed ID: 26328888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression and localization of decorin in human oral dysplasia and squamous cell carcinoma.
    Banerjee AG; Bhattacharyya I; Lydiatt WM; Vishwanatha JK
    Cancer Res; 2003 Nov; 63(22):7769-76. PubMed ID: 14633702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomic DNA Copy Number Aberrations, Histological Diagnosis, Oral Subsite and Aneuploidy in OPMDs/OSCCs.
    Castagnola P; Zoppoli G; Gandolfo S; Monticone M; Malacarne D; Cirmena G; Brown D; Aiello C; Maffei M; Marino R; Giaretti W; Pentenero M
    PLoS One; 2015; 10(11):e0142294. PubMed ID: 26540282
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
    Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
    J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of p63 protein and mRNA in oral epithelial dysplasia.
    Chen YK; Hsue SS; Lin LM
    J Oral Pathol Med; 2005 Apr; 34(4):232-9. PubMed ID: 15752259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predominant Rab-GTPase amplicons contributing to oral squamous cell carcinoma progression to metastasis.
    da Silva SD; Marchi FA; Xu B; Bijian K; Alobaid F; Mlynarek A; Rogatto SR; Hier M; Kowalski LP; Alaoui-Jamali MA
    Oncotarget; 2015 Sep; 6(26):21950-63. PubMed ID: 26110570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in silico validation of CA3 and FHL1 downregulation in oral cancer.
    Pereira CM; de Carvalho AC; da Silva FR; Melendez ME; Lessa RC; Andrade VCC; Kowalski LP; Vettore AL; Carvalho AL
    BMC Cancer; 2018 Feb; 18(1):193. PubMed ID: 29454310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrative molecular characterization of head and neck cancer cell model genomes.
    Tsui IF; Garnis C
    Head Neck; 2010 Sep; 32(9):1143-60. PubMed ID: 20014447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-211 Enhances the Oncogenicity of Carcinogen-Induced Oral Carcinoma by Repressing TCF12 and Increasing Antioxidant Activity.
    Chen YF; Yang CC; Kao SY; Liu CJ; Lin SC; Chang KW
    Cancer Res; 2016 Aug; 76(16):4872-86. PubMed ID: 27221705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.